Tags: prostate cancer

6/14/2018

Here’s one detail that should be included in almost all stories about cancer screening studies

4/25/2018

Guardian spoon-feeds university news release to readers, claiming prostate cancer ‘breakthrough’

2 4/4/2018

Prostate cancer gene test: WSJ skirts around lack of long-term data

2/7/2018

Disease-mongering dogs Bloomberg’s story on prostate cancer drugs

9/7/2017

STAT provides readers with necessary details to make sense of new PSA screening study

9/7/2017

LA Times portrays PSA screening analysis as far more clear-cut and definite than even the authors claim

6/21/2017

For story on experimental prostate cancer blood test, Guardian leans heavily on news release

4/26/2017

WSJ story on prostate procedure: No independent sources were quoted

2/8/2017

NY Times deftly describes findings of study on using hormone blockers for prostate cancer recurrence

2/8/2017

STAT said drug ‘halved’ prostate cancer deaths, but that’s not the full picture

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

National Breast Cancer Coalition @NBCCStopBC·

A lot of interesting workshops are happening now at the #NBCCSummit! @garyschwitzer, the publisher of @HealthNewsRevu, is discussing new cancer research news. #BeBold

Reply on Twitter 1520768892888567810 Retweet on Twitter 15207688928885678101 Like on Twitter 15207688928885678103 Twitter 1520768892888567810

HealthNewsReview.org @HealthNewsRevu·

Take all the issues enmeshed in any cancer screening story and amplify it with the liquid biopsy issue. @AP's ⁦@CarlaKJohnson⁩. did a solid job here. https://apnews.com/article/science-business-health-hodgkin-lymphoma-oregon-ca899bb9c4c7f1859d4e9ce16a1cf78d

Reply on Twitter 1516522980385472513 Retweet on Twitter 1516522980385472513 Like on Twitter 15165229803854725134 Twitter 1516522980385472513